Botulinum Toxins, Type ANeuromuscular AgentsBotulinum ToxinsMuscle SpasticityAnti-Dyskinesia AgentsClostridium botulinumInjections, IntramuscularBotulismBlepharospasmBotulinum AntitoxinTorticollisHyperhidrosisSialorrheaCosmetic TechniquesHemifacial SpasmParaparesis, SpasticSkin AgingMuscle Relaxants, CentralHypohidrosisInjectionsCerebral PalsyCryoanesthesiaSpasmHemiplegiaUpper ExtremityNeurotoxinsShiga Toxin 2Treatment OutcomeSweat GlandsPain MeasurementTetanus ToxinFissure in AnoMeige SyndromeClostridium botulinum type AParasympatholyticsClostridium botulinum type EStrokeShiga Toxin 1GaitCholera ToxinRange of Motion, ArticularDouble-Blind MethodDystoniaEsophageal AchalasiaFacial MusclesDystonic DisordersT-2 ToxinQuality-Adjusted Life YearsShiga ToxinsSweating, GustatorySpinal Cord InjuriesLethal Dose 50Dose-Response Relationship, DrugSynaptosomal-Associated Protein 25EnterotoxinsNeuromuscular JunctionBacterial ToxinsFollow-Up StudiesPatient SatisfactionToxins, BiologicalAntitoxinsOculomotor MusclesUrinary Bladder, OveractiveCost-Benefit AnalysisEquinus DeformityProspective StudiesClostridium botulinum type BClostridiumRejuvenationToxoidsClostridium botulinum type FToxemia